Fig. 2

Trends in age-standardised prevalence (A), incidence (B), mortality (C), and DALYs rates (D) of neuroblastoma and peripheral nervous system tumours among individuals aged 60 years and older, classified by gender, from 1990 to 2021. ASPR Age-standardized Prevalence Rate, ASIR Age-standardized Incidence Rate, ASMR Age-standardized Mortality Rate, ASDR Age-standardized, DALYs Disability-adjusted Life-Years